181 related articles for article (PubMed ID: 31743734)
1. Drug Screen Identifies Leflunomide for Treatment of Inflammatory Bowel Disease Caused by TTC7A Deficiency.
Jardine S; Anderson S; Babcock S; Leung G; Pan J; Dhingani N; Warner N; Guo C; Siddiqui I; Kotlarz D; Dowling JJ; Melnyk RA; Snapper SB; Klein C; Thiagarajah JR; Muise AM
Gastroenterology; 2020 Mar; 158(4):1000-1015. PubMed ID: 31743734
[TBL] [Abstract][Full Text] [Related]
2. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease.
Avitzur Y; Guo C; Mastropaolo LA; Bahrami E; Chen H; Zhao Z; Elkadri A; Dhillon S; Murchie R; Fattouh R; Huynh H; Walker JL; Wales PW; Cutz E; Kakuta Y; Dudley J; Kammermeier J; Powrie F; Shah N; Walz C; Nathrath M; Kotlarz D; Puchaka J; Krieger JR; Racek T; Kirchner T; Walters TD; Brumell JH; Griffiths AM; Rezaei N; Rashtian P; Najafi M; Monajemzadeh M; Pelsue S; McGovern DP; Uhlig HH; Schadt E; Klein C; Snapper SB; Muise AM
Gastroenterology; 2014 Apr; 146(4):1028-39. PubMed ID: 24417819
[TBL] [Abstract][Full Text] [Related]
3. Immune deficiency-related enteropathy-lymphocytopenia-alopecia syndrome results from tetratricopeptide repeat domain 7A deficiency.
Lemoine R; Pachlopnik-Schmid J; Farin HF; Bigorgne A; Debré M; Sepulveda F; Héritier S; Lemale J; Talbotec C; Rieux-Laucat F; Ruemmele F; Morali A; Cathebras P; Nitschke P; Bole-Feysot C; Blanche S; Brousse N; Picard C; Clevers H; Fischer A; de Saint Basile G
J Allergy Clin Immunol; 2014 Dec; 134(6):1354-1364.e6. PubMed ID: 25174867
[TBL] [Abstract][Full Text] [Related]
4. TTC7A: Steward of Intestinal Health.
Jardine S; Dhingani N; Muise AM
Cell Mol Gastroenterol Hepatol; 2019; 7(3):555-570. PubMed ID: 30553809
[TBL] [Abstract][Full Text] [Related]
5. Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias.
Chen R; Giliani S; Lanzi G; Mias GI; Lonardi S; Dobbs K; Manis J; Im H; Gallagher JE; Phanstiel DH; Euskirchen G; Lacroute P; Bettinger K; Moratto D; Weinacht K; Montin D; Gallo E; Mangili G; Porta F; Notarangelo LD; Pedretti S; Al-Herz W; Alfahdli W; Comeau AM; Traister RS; Pai SY; Carella G; Facchetti F; Nadeau KC; Snyder M; Notarangelo LD
J Allergy Clin Immunol; 2013 Sep; 132(3):656-664.e17. PubMed ID: 23830146
[TBL] [Abstract][Full Text] [Related]
6. Multiple intestinal atresia with combined immune deficiency related to TTC7A defect is a multiorgan pathology: study of a French-Canadian-based cohort.
Fernandez I; Patey N; Marchand V; Birlea M; Maranda B; Haddad E; Decaluwe H; Le Deist F
Medicine (Baltimore); 2014 Dec; 93(29):e327. PubMed ID: 25546680
[TBL] [Abstract][Full Text] [Related]
7. Chronic Intestinal Pseudo-Obstruction and Lymphoproliferative Syndrome as a Novel Phenotype Associated With Tetratricopeptide Repeat Domain 7A Deficiency.
El-Daher MT; Lemale J; Bruneau J; Leveau C; Guerin F; Lambert N; Diana JS; Neven B; Sepulveda FE; Coulomb-L'Hermine A; Molina T; Picard C; Fischer A; de Saint Basile G
Front Immunol; 2019; 10():2592. PubMed ID: 31787977
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Gastrointestinal Histopathology in Patients With Tetratricopeptide Repeat Domain 7A (TTC7A) Germline Mutations: A Rare Condition Leading to Multiple Intestinal Atresias, Severe Combined Immunodeficiency, and Congenital Enteropathy.
Dannheim K; Ouahed J; Field M; Snapper S; Raphael BP; Glover SC; Bishop PR; Bhesania N; Kamin D; Thiagarajah J; Goldsmith JD
Am J Surg Pathol; 2022 Jun; 46(6):846-853. PubMed ID: 34985046
[TBL] [Abstract][Full Text] [Related]
9. The E3 ubiquitin ligase UBR5 interacts with TTC7A and may be associated with very early onset inflammatory bowel disease.
Dhingani N; Guo C; Pan J; Li Q; Warner N; Jardine S; Leung G; Kotlarz D; Gonzaga-Jauregui C; Klein C; Snapper SB; Navas-López VM; Muise AM
Sci Rep; 2020 Oct; 10(1):18648. PubMed ID: 33122718
[TBL] [Abstract][Full Text] [Related]
10. Meconium peritonitis in multiple intestinal atresia with combined immune deficiency caused by a
Chen J; Chen M; Lin Y; Li X
SAGE Open Med Case Rep; 2024; 12():2050313X241227129. PubMed ID: 38292879
[TBL] [Abstract][Full Text] [Related]
11. A Novel Homozygous
Mou W; Yang S; Guo R; Fu L; Zhang L; Guo W; Du J; He J; Ren Q; Hao C; Gui J; Huang J
Front Immunol; 2021; 12():759308. PubMed ID: 34975848
[TBL] [Abstract][Full Text] [Related]
12. TTC7A mutations disrupt intestinal epithelial apicobasal polarity.
Bigorgne AE; Farin HF; Lemoine R; Mahlaoui N; Lambert N; Gil M; Schulz A; Philippet P; Schlesser P; Abrahamsen TG; Oymar K; Davies EG; Ellingsen CL; Leteurtre E; Moreau-Massart B; Berrebi D; Bole-Feysot C; Nischke P; Brousse N; Fischer A; Clevers H; de Saint Basile G
J Clin Invest; 2014 Jan; 124(1):328-37. PubMed ID: 24292712
[TBL] [Abstract][Full Text] [Related]
13. Combined Immunodeficiency With Inflammatory Bowel Disease in a Patient With TTC7A Deficiency.
Broome DT; Young A; Torbic H; Krishnan S; Gordon I; Lai K; Rizk M; Rieder F
ACG Case Rep J; 2019 May; 6(5):e00061. PubMed ID: 31616743
[TBL] [Abstract][Full Text] [Related]
14. Missense mutation of TTC7A mimicking tricho-hepato-enteric (SD/THE) syndrome in a patient with very-early onset inflammatory bowel disease.
Neves JF; Afonso I; Borrego L; Martins C; Cordeiro AI; Neves C; Lacoste C; Badens C; Fabre A
Eur J Med Genet; 2018 Apr; 61(4):185-188. PubMed ID: 29174094
[TBL] [Abstract][Full Text] [Related]
15. Novel Mutations of the
Lien R; Lin YF; Lai MW; Weng HY; Wu RC; Jaing TH; Huang JL; Tsai SF; Lee WI
Front Immunol; 2017; 8():1066. PubMed ID: 28936210
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells.
Grabinger T; Bode KJ; Demgenski J; Seitz C; Delgado ME; Kostadinova F; Reinhold C; Etemadi N; Wilhelm S; Schweinlin M; Hänggi K; Knop J; Hauck C; Walles H; Silke J; Wajant H; Nachbur U; W Wei-Lynn W; Brunner T
Gastroenterology; 2017 Mar; 152(4):867-879. PubMed ID: 27889570
[TBL] [Abstract][Full Text] [Related]
17. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
Chiriac MT; Buchen B; Wandersee A; Hundorfean G; Günther C; Bourjau Y; Doyle SE; Frey B; Ekici AB; Büttner C; Weigmann B; Atreya R; Wirtz S; Becker C; Siebler J; Neurath MF
Gastroenterology; 2017 Jul; 153(1):123-138.e8. PubMed ID: 28342759
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers.
Aguilar C; Lenoir C; Lambert N; Bègue B; Brousse N; Canioni D; Berrebi D; Roy M; Gérart S; Chapel H; Schwerd T; Siproudhis L; Schäppi M; Al-Ahmari A; Mori M; Yamaide A; Galicier L; Neven B; Routes J; Uhlig HH; Koletzko S; Patel S; Kanegane H; Picard C; Fischer A; Bensussan NC; Ruemmele F; Hugot JP; Latour S
J Allergy Clin Immunol; 2014 Nov; 134(5):1131-41.e9. PubMed ID: 24942515
[TBL] [Abstract][Full Text] [Related]
19. Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells.
Baumann P; Mandl-Weber S; Völkl A; Adam C; Bumeder I; Oduncu F; Schmidmaier R
Mol Cancer Ther; 2009 Feb; 8(2):366-75. PubMed ID: 19174558
[TBL] [Abstract][Full Text] [Related]
20. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
